Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study
CLINICAL CANCER RESEARCH, vol.25, no.7, pp.2127-2135, 2019 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 25 Issue: 7
- Publication Date: 2019
- Doi Number: 10.1158/1078-0432.ccr-18-3696
- Journal Name: CLINICAL CANCER RESEARCH
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.2127-2135
- Open Archive Collection: AVESIS Open Access Collection
- Hacettepe University Affiliated: No
Abstract
Purpose: Barrett's esophagus is the only known precursor of esophageal adenocarcinoma (EAC). Although endoscopy and biopsy are standard methods for Barrett's esophagus diagnosis, their high cost and risk limit their use as a screening modality. Here, we sought to develop a Barrett's esophagus detection method based on methylation status in cytology samples captured by EsophaCap using a streamlined sensitive technique, methylation on beads (MOB).